301502 Jiangsu Huayang Intelligent Equipment
- 36.59
- -0.75-2.01%
Jiangsu Huayang Intelligent Equipment News
Huayang Intelligence (301502.SZ): 2023 equity distribution, 10 distributions of 5.25 yuan, share registration date June 4
On May 28, Ge Longhui | Huayang Intelligence (301502.SZ) announced that the company's 2023 equity distribution plan is to distribute 5.2,500 yuan in cash (tax included) to all shareholders for every 10 shares based on the company's current total share capital of 57,083,500 shares. The share registration date for this equity distribution is June 4, 2024, and the ex-dividend date is June 5, 2024.
Express News | Huayang Intelligence: The company's products are not currently involved in medical and aesthetic applications
Huayang Intelligence (301502.SZ): Net profit of 7.7889 million yuan in the first quarter decreased by 42.47% year-on-year
Gelonghui, April 28, 丨 Huayang Intelligence (301502.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 110 million yuan, up 2.32% year on year; net profit attributable to shareholders of listed companies was 7.788 million yuan, down 42.47% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 802.34 million yuan, down 33.55% year on year; basic earnings per share were 0.1724 yuan.
Huayang Intelligence (301502.SZ) announced its 2023 annual results, with net profit of 65.3533 million yuan, an increase of 2.92%
Huayang Intelligence (301502.SZ) released its 2023 annual report. The company's revenue was 476 million yuan...
Express News | Huayang Intelligence: Precision drug delivery devices will be released as pharmaceutical companies launch new products
Huayang Intelligence (301502.SZ): The motor with the deceleration mechanism was developed by itself
Gelonghui March 19 丨 An investor asked Huayang Intelligence (301502.SZ) on the investor interactive platform, “Does the company already use its own pegs? If not, why?” The company replied that the company developed its own motor with a deceleration mechanism.
Huayang Intelligence (301502.SZ): Motors are not currently used in robots
Gelonghui March 19 丨 An investor asked Huayang Intelligence (301502.SZ) on the investor interactive platform, “Can the company's motor products equipped with speed reducers be used in robots, or in any other field?” The company replied that the company's motors are not currently used in robots.
Jiangsu Huayang Intelligent Equipment Opens Books For 806.5 Million Yuan Shenzhen IPO
Pamica Technology Corp. (SHE:001359) has started taking subscriptions on Friday for its 806.5 million yuan initial public offering on the Shenzhen Stock Exchange's main board. The Chinese manufacturer
Express News | Huayang Intelligence said on an interactive platform today that the company's motors are not connected to Preferred Choice for the time being.
Express News | Huayang Intelligence: Mechanical pens have been used in pharmaceutical fields such as growth hormone, follicle-stimulating hormone, liraglutide, and simeglutide
Huayang Intelligence: Electronic injection pens have expanded to other pharmaceutical fields, and there is a lot of future market space
Gelonghui, Feb. 28 | Huayang Intelligence said in an online exchange meeting with institutional investors that at present, the company's precision drug delivery devices are mainly divided into electronic and mechanical injection pens. Electronic injection pens are the company's core product, and the application of electronic injection pens to growth hormone accounts for about 65% of the revenue from drug delivery devices. The application of electronic pens has also been expanded to other drugs, such as osteoporosis treatment, and the application of the simeglutide market is being developed simultaneously.
Huayang Intelligence (301502 .SZ): The main products are micro motors and components, and precision drug delivery devices
On February 8, Gelonghui | Huayang Intelligence (301502 .SZ) said on the investor interactive platform that the company's main products are micro motors and components, and precision drug delivery devices.
Huayang Intelligence (301502 .SZ): Precision dosing syringe products can be used for precise administration of drugs in assisted reproduction
Gelonghui, Feb. 8 | Huayang Intelligence (301502.SZ) said on the investor interactive platform that the company's precision dosing syringe products can be used for precise administration of assisted reproductive medicine.
Jiangsu Huayang Intelligent Equipment Jumps 102% in Shenzhen Trading Debut
Jiangsu Huayang Intelligent Equipment (SHE:301502) rose 102% Friday morning when it started trading on the Shenzhen Stock Exchange's ChiNext board. Shares of the Chinese manufacturer of power generati
A-share IPO news: Haisheng Pharmaceutical (870656) and Huayang Smart (301502.SZ) are listed today
Gelonghui, Feb. 2 | Haisheng Pharmaceutical (870656) and Huayang Smart (301502.SZ) went public today, and there are no new shares to be purchased today.
Huayang Smart (301502 .SZ): Will be listed on the Shenzhen Stock Exchange on February 2
Gelonghui January 31 | Huayang Intelligence (301502 .SZ) announced that the company's stock will be listed on the Shenzhen Stock Exchange on February 2, 2024.
Oral simeglutide was approved for listing in China. Nearly 20 listed companies' interactive platforms respond to related business layouts
Glonghui, January 27 | Novo Nordisk's simeglu peptide tablets were approved for marketing by the State Drug Administration. This is the first oral GLP-1 receptor agonist approved for marketing in China. According to an incomplete analysis by the Financial Federation, since this year, six listed companies, including Huadong Pharmaceutical, Huayang Intelligence, Fosun Pharmaceuticals, Puli Pharmaceuticals, Hanyu Pharmaceutical, and Shengnuo Biotech, have returned with business layouts related to simeglutide on interactive platforms. In addition, it includes Yixintang, Borui Pharmaceutical, Health Yuan, Ganli Pharmaceutical, Jincheng Pharmaceutical, Dezhan Health, Wanbang Pharmaceuticals, Nuotai Biotech, Pluo Pharmaceuticals, Pearl Group, Aimeike, China Resources Shuanghe, and Jinkai Shengke
Huayang Intelligence (301502.SZ) revealed the winning results: there were 138.43 million winning numbers
Gelonghui, January 25 | Huayang Intelligence (301502 .SZ) announced the initial public offering and the results of the online GEM listing. The details are as follows: Any investor participating in this online pricing offering to purchase the initial public offering of Jiangsu Huayang Intelligent Equipment Co., Ltd. holds the last number of subscription codes with the same number as above, then it is the winning number. There are 138.43 million winning numbers. Each winning number can only subscribe for 500 A-shares of Jiangsu Huayang Intelligent Equipment Co., Ltd.
Huayang Smart (301502.SZ) has a winning rate of 0.0255% for online distribution after the callback
Huayang Intelligence (301502.SZ) announced that the number of valid subscribers for the company's online initial public offering of shares was 7...
Huayang Intelligent Equipment Opens Books For 400 Million Yuan Shenzhen IPO
Jiangsu Huayang Intelligent Equipment (SHE:301502) has started taking subscriptions on Wednesday for its 399.7 million yuan initial public offering on the Shenzhen Stock Exchange's ChiNext board. The
Analysis
Price Target
No Data
